Conclude your conference experience with the EuroPCR 2025 Closing Ceremony, celebrating the achievements, innovations, and advancements presented throughout the event, and setting the stage for future developments in interventional cardiology.

Celebrate innovation and research excellence in interventional cardiology with the Jon DeHaan Foundation Award and Michele Pighi Young Investigator Award session. This session highlights groundbreaking work and emerging talent shaping the future of cardiovascular interventions.

This live educational session focuses on the management of calcified left main bifurcation lesions, emphasizing the critical role of intravascular imaging for procedural planning and optimization. It highlights the use of mechanical lithoplasty for calcium modification prior to stent implantation and outlines strategic considerations for successful...

Luis Ortega provides his take on the SEISMIC-HF I study presented by Liviu Klein at AHA 2024, in Chicago.

Aaysha Cader and Ali Nazmi Calik provide their take on the BHF PROTECT-TAVI trial, presented by Rajesh Kharbanda at ACC.25 in Chicago.

This image highlights the challenges of managing infective endocarditis (IE) and explores the potential role of transcatheter extraction devices in addressing unmet needs for patients who cannot undergo surgery.

Pamela Gatto provides her take on the Intrepid Global Pilot Study which was presented by Renuka Jain at TCT Congress 2022.

Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.

Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...

Impella CP microaxial flow pump supports complete revascularisation during high-risk PCI, but standard implantation often leads to vascular complications. This article explores an initial experience with a sheathless implantation technique, which shows promise as a feasible and safe alternative.

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among which is the...

Ali Nazmi Calik provides his take on the FLAVOUR II trial presented by Jian-An Wang at ACC.25 in Chicago.